Notably, it apparently reduced ECM density and lowered the presence of activated stellate cells
In a randomized, single-blind, 24-week study, participants assigned to dual therapy of 2 mg weekly of the GLP-1 receptor agonist exenatide (Bydureon, AstraZeneca) and 10 mg daily of the SGLT2 inhibitor dapagliflozin (Farxiga, AstraZeneca) lost more weight than those taking either agent alone or those receiving dapagliflozin and metformin extended-release (Xigduo XL, AstraZeneca) or phentermine/topiramate extended-release (Qsymia, Vivus)
Adults with any class of obesity had lower odds for receiving an antiemetic prescription if they used an incretin-based medication compared with nonusers, but no association was observed for those without obesity
Something else the gps arent aware of
Some individuals may experience bloating, nausea, abdominal discomfort or diarrhoea
Mechanotransduction for Muscle Protein Synthesis via Mechanically Activated Ion Channels